多次给予钆布醇后脑部MRI及定量磁敏感图:一项纵向随访研究
本研究为单中心回顾性研究,纳入90例原发性脑肿瘤患者共199次MRI扫描,分析多次给予大环状钆布醇后QSM能否检测苍白球和齿状核磁敏感度变化。结果显示钆布醇注射次数与苍白球磁敏感度升高相关(校正后1.3×10⁻³ ppm/次,95%CI:0.39×10⁻³,-2.4×10⁻³,P=.006),齿状核T1信号强度及磁敏感度均无关联。
要点
- 多次给予钆布醇后,苍白球磁敏感度随注射次数增加而升高。
- 齿状核T1信号强度及磁敏感度与钆布醇注射次数无关联。
- QSM可用于定量检测大环状对比剂多次给药后的脑内磁敏感度变化。
核心结论
- 多次给予钆布醇后,苍白球磁敏感度升高。
研究设计与样本
- 单中心回顾性研究,2014年8月至2019年2月纳入90例原发性脑肿瘤成人患者(平均年龄51岁±17,51例男性),共199次MRI扫描。
- 纳入501例连续成人患者中至少接受一次钆布醇注射者,排除既往使用未知或线性钆对比剂者。
- 基于三维梯度回波序列相位数据行QSM处理,在半自动阈值分割基础上于苍白球和齿状核勾画感兴趣区。
- 采用单变量广义估计方程分析MRI指标(T1WI信号强度及QSM磁敏感度)与钆布醇注射次数的关联,多变量广义估计方程校正潜在混杂因素。
关键影像表现/征象
- 苍白球磁敏感度随钆布醇注射次数增加而升高:单变量模型为1.4×10⁻³ ppm/次(P=.01),校正混杂因素后为1.3×10⁻³ ppm/次(95%CI:0.39×10⁻³,-2.4×10⁻³;P=.006)。
- 齿状核磁敏感度与钆布醇注射次数无关联(单变量模型8.1×10⁻⁴ ppm/次,P=.03;校正后未保持独立预测意义)。
- 齿状核T1WI信号强度与钆布醇注射次数无关联。
临床应用与阅片要点
- 作者结论指出,多次给予钆布醇后苍白球磁敏感度升高,QSM可定量检测该变化。
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background The relationship between administration of macrocyclic gadolinium-based contrast agents and T1-weighted signal intensity (SI) change of the globus pallidus (GP) and dentate nucleus (DN) is, to the knowledge of the authors, not known. Purpose To determine if quantitative susceptibility mapping (QSM) can detect changes in magnetic susceptibility of the GP and DN after serial administration of macrocyclic gadobutrol in patients with primary brain tumors. Materials and Methods Patients diagnosed with primary brain tumors from August 2014 to February 2019 were eligible for this single-center retrospective study. Among 501 consecutive adult patients who were given at least one administration of gadobutrol, those who were previously administered an unknown or linear gadolinium-based contrast agent were excluded. Brain MRI scans with three-dimensional gradient-recalled-echo image phase data for QSM processing were reviewed. Regions of interest were drawn on the GP and DN on the basis of semiautomatic thresholding. Univariable generalized estimation equations were used to determine the associations between MRI measures (SI on T1-weighted images and magnetic susceptibility on QSM) and number of gadobutrol doses. Potential confounding factors were adjusted for in multivariable generalized estimating equation. Results Ninety patients (mean age, 51 years ± 17 [standard deviation]; 51 men) with 199 MRI scans were analyzed. In models adjusted for repeated observations between injections, the number of injections of gadobutrol was associated with the magnetic susceptibility of the GP (1.4 × 10-3 ppm/number of gadobutrol injections; P = .01) and DN (8.1 × 10-4 ppm/number of gadobutrol injections; P = .03). After adjustment for confounders, the number of gadobutrol injections remained an independent predictor of increased magnetic susceptibility in the GP (1.3 × 10-3 ppm/number of gadobutrol injections; 95% confidence interval: 0.39 × 10-3, -2.4 × 10-3; P = .006). There were no associations between number of gadobutrol injections and SI or magnetic susceptibility in the DN. Conclusion The magnetic susceptibility of the globus pallidus increased after serial administration of gadobutrol. © RSNA, 2020 Online supplemental material is available for this article. See also the editorial by Wang and Prince in this issue.
引用
- Choi Y, Jang J, Kim J, et al. MRI and Quantitative Magnetic Susceptibility Maps of the Brain after Serial Administration of Gadobutrol: A Longitudinal Follow-up Study. Radiology. 2020. PMID: 32692298. doi:10.1148/radiol.2020192579
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。